Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 15Gynecologic 4Sarcoma 2Lymphoid 2Thoracic 1Other hematologic neoplasm 1Breast 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Follicular 1Heart Defects, Congenital 1Coma 1Cerebrovascular Disorders 1Brain Injuries, Traumatic 1

Interventions

Rituximab 1401Cyclophosphamide 1306Vincristine 668Doxorubicin 587Etoposide 527Prednisone 511Cytarabine 486fludarabine 470Methotrexate 445Dexamethasone 413fludarabine phosphate 400Lenalidomide 356Filgrastim 343Bendamustine Hydrochloride 282Radiotherapy 267venetoclax 261ibrutinib 258obinutuzumab 236Peripheral Blood Stem Cell Transplantation 234Melphalan 230Granulocyte Colony-Stimulating Factor 215Bortezomib 204Gemcitabine 202Busulfan 188Whole-Body Irradiation 187Mycophenolic Acid 175Tacrolimus 165Specimen Handling 162Magnetic Resonance Spectroscopy 155Calcium Dobesilate 150

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Enhanced Recovery After Surgery × Lymphoid × Clear all
NCT06241482 2025-03-04

Safety and Efficacy of Enhanced Recovery After Surgery in Neurocritical Care

Shanghai 6th People's Hospital

Phase NA Recruiting
80 enrolled
Lymphoid

Brain Injuries, Traumatic, Cerebrovascular Disorders, Coma, Lymphoma, Follicular

NCT05665712 2023-10-05

PERCS

University of Alberta

Completed
483 enrolled
LymphoidOther hematologic neoplasm

Heart Defects, Congenital, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡